.tb-grid,.tb-grid>.block-editor-inner-blocks>.block-editor-block-list__layout{display:grid;grid-row-gap:25px;grid-column-gap:25px}.tb-grid-item{background:#d38a03;padding:30px}.tb-grid-column{flex-wrap:wrap}.tb-grid-column>*{width:100%}.tb-grid-column.tb-grid-align-top{width:100%;display:flex;align-content:flex-start}.tb-grid-column.tb-grid-align-center{width:100%;display:flex;align-content:center}.tb-grid-column.tb-grid-align-bottom{width:100%;display:flex;align-content:flex-end} .wpv-view-output[data-toolset-views-view-editor="398b1c497a9ce286fa1c53fda77b18cb"] > .tb-grid-column:nth-of-type(3n + 1) { grid-column: 1 } .wpv-view-output[data-toolset-views-view-editor="398b1c497a9ce286fa1c53fda77b18cb"] > .tb-grid-column:nth-of-type(3n + 2) { grid-column: 2 } .wpv-view-output[data-toolset-views-view-editor="398b1c497a9ce286fa1c53fda77b18cb"] > .tb-grid-column:nth-of-type(3n + 3) { grid-column: 3 } .wpv-view-output[data-toolset-views-view-editor="398b1c497a9ce286fa1c53fda77b18cb"] .js-wpv-loop-wrapper > .tb-grid { grid-template-columns: minmax(0, 0.3333fr) minmax(0, 0.3333fr) minmax(0, 0.3333fr);grid-auto-flow: row } .wpv-view-output[data-toolset-views-view-editor="398b1c497a9ce286fa1c53fda77b18cb"] .tb-masonry { grid-template-columns: minmax(0, 1fr) minmax(0, 1fr);grid-column-gap: 10px; } .wpv-view-output[data-toolset-views-view-editor="398b1c497a9ce286fa1c53fda77b18cb"] .tb-masonry .tb-brick__content { padding: 0 0 10px 0; } .wpv-pagination-nav-links[data-toolset-views-view-pagination-block="95f5751cc2f80f4b7d21b100ff8b624f"] { text-align: left;justify-content: flex-start; } .tb-container .tb-container-inner{width:100%;margin:0 auto} .wp-block-toolset-blocks-container.tb-container[data-toolset-blocks-container="40b05292f70a70284b1c1668151484af"] { background: rgba( 250, 246, 246, 1 );padding: 0px;border: 1px solid rgba( 218, 218, 218, 1 ); } .tb-container .tb-container-inner{width:100%;margin:0 auto} .wp-block-toolset-blocks-container.tb-container[data-toolset-blocks-container="15799f218876513e85a62246af23d50a"] { padding: 15px 20px 10px 20px;margin-top: 0px;border: 0px solid rgba( 0, 0, 0, 1 ); } .tb-fields-and-text[data-toolset-blocks-fields-and-text="8d670a655444748b596f1fb0c7115269"] { color: rgba( 0, 0, 0, 1 );margin-bottom: 10px; } .tb-fields-and-text[data-toolset-blocks-fields-and-text="8d670a655444748b596f1fb0c7115269"] p { color: rgba( 0, 0, 0, 1 ); }  .tb-image{position:relative;transition:transform 0.25s ease}.wp-block-image .tb-image.aligncenter{margin-left:auto;margin-right:auto}.tb-image img{max-width:100%;height:auto;width:auto;transition:transform 0.25s ease}.tb-image .tb-image-caption-fit-to-image{display:table}.tb-image .tb-image-caption-fit-to-image .tb-image-caption{display:table-caption;caption-side:bottom} .wp-block-image.tb-image[data-toolset-blocks-image="7d618f72fcf8cf3093933d1e4b7feb11"] { max-width: 100%; } .wp-block-image.tb-image[data-toolset-blocks-image="7d618f72fcf8cf3093933d1e4b7feb11"] img { background-color: rgba( 250, 246, 246, 1 );border: 0px solid rgba( 0, 0, 0, 1 ); } .tb-button{color:#f1f1f1}.tb-button--left{text-align:left}.tb-button--center{text-align:center}.tb-button--right{text-align:right}.tb-button__link{color:inherit;cursor:pointer;display:inline-block;line-height:100%;text-decoration:none !important;text-align:center;transition:all 0.3s ease}.tb-button__link:hover,.tb-button__link:focus,.tb-button__link:visited{color:inherit}.tb-button__link:hover .tb-button__content,.tb-button__link:focus .tb-button__content,.tb-button__link:visited .tb-button__content{font-family:inherit;font-style:inherit;font-weight:inherit;letter-spacing:inherit;text-decoration:inherit;text-shadow:inherit;text-transform:inherit}.tb-button__content{vertical-align:middle;transition:all 0.3s ease}.tb-button__icon{transition:all 0.3s ease;display:inline-block;vertical-align:middle;font-style:normal !important}.tb-button__icon::before{content:attr(data-font-code);font-weight:normal !important}.tb-button__link{background-color:#444;border-radius:0.3em;font-size:1.3em;margin-bottom:0.76em;padding:0.55em 1.5em 0.55em} .tb-button[data-toolset-blocks-button="d38c7b1e6196431e002ed2a380201dca"] .tb-button__link { background-color: rgba( 207, 46, 46, 1 );font-size: 12px;text-transform: capitalize; } .tb-button[data-toolset-blocks-button="d38c7b1e6196431e002ed2a380201dca"] .tb-button__icon { font-family: dashicons; } .tb-button{color:#f1f1f1}.tb-button--left{text-align:left}.tb-button--center{text-align:center}.tb-button--right{text-align:right}.tb-button__link{color:inherit;cursor:pointer;display:inline-block;line-height:100%;text-decoration:none !important;text-align:center;transition:all 0.3s ease}.tb-button__link:hover,.tb-button__link:focus,.tb-button__link:visited{color:inherit}.tb-button__link:hover .tb-button__content,.tb-button__link:focus .tb-button__content,.tb-button__link:visited .tb-button__content{font-family:inherit;font-style:inherit;font-weight:inherit;letter-spacing:inherit;text-decoration:inherit;text-shadow:inherit;text-transform:inherit}.tb-button__content{vertical-align:middle;transition:all 0.3s ease}.tb-button__icon{transition:all 0.3s ease;display:inline-block;vertical-align:middle;font-style:normal !important}.tb-button__icon::before{content:attr(data-font-code);font-weight:normal !important}.tb-button__link{background-color:#444;border-radius:0.3em;font-size:1.3em;margin-bottom:0.76em;padding:0.55em 1.5em 0.55em} .tb-button[data-toolset-blocks-button="d2e2b11f87f20192f81acf521a2702ac"] .tb-button__link { background-color: rgba( 155, 81, 224, 1 );font-size: 12px;text-transform: capitalize; } .tb-button[data-toolset-blocks-button="d2e2b11f87f20192f81acf521a2702ac"] .tb-button__icon { font-family: dashicons; } @media only screen and (max-width: 781px) { .tb-grid,.tb-grid>.block-editor-inner-blocks>.block-editor-block-list__layout{display:grid;grid-row-gap:25px;grid-column-gap:25px}.tb-grid-item{background:#d38a03;padding:30px}.tb-grid-column{flex-wrap:wrap}.tb-grid-column>*{width:100%}.tb-grid-column.tb-grid-align-top{width:100%;display:flex;align-content:flex-start}.tb-grid-column.tb-grid-align-center{width:100%;display:flex;align-content:center}.tb-grid-column.tb-grid-align-bottom{width:100%;display:flex;align-content:flex-end} .wpv-view-output[data-toolset-views-view-editor="398b1c497a9ce286fa1c53fda77b18cb"] > .tb-grid-column:nth-of-type(3n + 1) { grid-column: 1 } .wpv-view-output[data-toolset-views-view-editor="398b1c497a9ce286fa1c53fda77b18cb"] > .tb-grid-column:nth-of-type(3n + 2) { grid-column: 2 } .wpv-view-output[data-toolset-views-view-editor="398b1c497a9ce286fa1c53fda77b18cb"] > .tb-grid-column:nth-of-type(3n + 3) { grid-column: 3 } .wpv-view-output[data-toolset-views-view-editor="398b1c497a9ce286fa1c53fda77b18cb"] .js-wpv-loop-wrapper > .tb-grid { grid-template-columns: minmax(0, 0.3333fr) minmax(0, 0.3333fr) minmax(0, 0.3333fr);grid-auto-flow: row } .wpv-view-output[data-toolset-views-view-editor="398b1c497a9ce286fa1c53fda77b18cb"] .tb-masonry { grid-template-columns: minmax(0, 1fr) minmax(0, 1fr);grid-column-gap: 10px; } .wpv-view-output[data-toolset-views-view-editor="398b1c497a9ce286fa1c53fda77b18cb"] .tb-masonry .tb-brick__content { padding: 0 0 10px 0; } .tb-container .tb-container-inner{width:100%;margin:0 auto}.tb-container .tb-container-inner{width:100%;margin:0 auto} .tb-image{position:relative;transition:transform 0.25s ease}.wp-block-image .tb-image.aligncenter{margin-left:auto;margin-right:auto}.tb-image img{max-width:100%;height:auto;width:auto;transition:transform 0.25s ease}.tb-image .tb-image-caption-fit-to-image{display:table}.tb-image .tb-image-caption-fit-to-image .tb-image-caption{display:table-caption;caption-side:bottom}.tb-button{color:#f1f1f1}.tb-button--left{text-align:left}.tb-button--center{text-align:center}.tb-button--right{text-align:right}.tb-button__link{color:inherit;cursor:pointer;display:inline-block;line-height:100%;text-decoration:none !important;text-align:center;transition:all 0.3s ease}.tb-button__link:hover,.tb-button__link:focus,.tb-button__link:visited{color:inherit}.tb-button__link:hover .tb-button__content,.tb-button__link:focus .tb-button__content,.tb-button__link:visited .tb-button__content{font-family:inherit;font-style:inherit;font-weight:inherit;letter-spacing:inherit;text-decoration:inherit;text-shadow:inherit;text-transform:inherit}.tb-button__content{vertical-align:middle;transition:all 0.3s ease}.tb-button__icon{transition:all 0.3s ease;display:inline-block;vertical-align:middle;font-style:normal !important}.tb-button__icon::before{content:attr(data-font-code);font-weight:normal !important}.tb-button__link{background-color:#444;border-radius:0.3em;font-size:1.3em;margin-bottom:0.76em;padding:0.55em 1.5em 0.55em}.tb-button{color:#f1f1f1}.tb-button--left{text-align:left}.tb-button--center{text-align:center}.tb-button--right{text-align:right}.tb-button__link{color:inherit;cursor:pointer;display:inline-block;line-height:100%;text-decoration:none !important;text-align:center;transition:all 0.3s ease}.tb-button__link:hover,.tb-button__link:focus,.tb-button__link:visited{color:inherit}.tb-button__link:hover .tb-button__content,.tb-button__link:focus .tb-button__content,.tb-button__link:visited .tb-button__content{font-family:inherit;font-style:inherit;font-weight:inherit;letter-spacing:inherit;text-decoration:inherit;text-shadow:inherit;text-transform:inherit}.tb-button__content{vertical-align:middle;transition:all 0.3s ease}.tb-button__icon{transition:all 0.3s ease;display:inline-block;vertical-align:middle;font-style:normal !important}.tb-button__icon::before{content:attr(data-font-code);font-weight:normal !important}.tb-button__link{background-color:#444;border-radius:0.3em;font-size:1.3em;margin-bottom:0.76em;padding:0.55em 1.5em 0.55em} } @media only screen and (max-width: 599px) { .tb-grid,.tb-grid>.block-editor-inner-blocks>.block-editor-block-list__layout{display:grid;grid-row-gap:25px;grid-column-gap:25px}.tb-grid-item{background:#d38a03;padding:30px}.tb-grid-column{flex-wrap:wrap}.tb-grid-column>*{width:100%}.tb-grid-column.tb-grid-align-top{width:100%;display:flex;align-content:flex-start}.tb-grid-column.tb-grid-align-center{width:100%;display:flex;align-content:center}.tb-grid-column.tb-grid-align-bottom{width:100%;display:flex;align-content:flex-end} .wpv-view-output[data-toolset-views-view-editor="398b1c497a9ce286fa1c53fda77b18cb"]  > .tb-grid-column:nth-of-type(1n+1) { grid-column: 1 } .wpv-view-output[data-toolset-views-view-editor="398b1c497a9ce286fa1c53fda77b18cb"] .js-wpv-loop-wrapper > .tb-grid { grid-template-columns: minmax(0, 1fr);grid-auto-flow: row } .wpv-view-output[data-toolset-views-view-editor="398b1c497a9ce286fa1c53fda77b18cb"] .tb-masonry { grid-template-columns: minmax(0, 1fr);grid-column-gap: 10px; } .wpv-view-output[data-toolset-views-view-editor="398b1c497a9ce286fa1c53fda77b18cb"] .tb-masonry .tb-brick__content { padding: 0 0 10px 0; } .tb-container .tb-container-inner{width:100%;margin:0 auto}.tb-container .tb-container-inner{width:100%;margin:0 auto} .tb-image{position:relative;transition:transform 0.25s ease}.wp-block-image .tb-image.aligncenter{margin-left:auto;margin-right:auto}.tb-image img{max-width:100%;height:auto;width:auto;transition:transform 0.25s ease}.tb-image .tb-image-caption-fit-to-image{display:table}.tb-image .tb-image-caption-fit-to-image .tb-image-caption{display:table-caption;caption-side:bottom}.tb-button{color:#f1f1f1}.tb-button--left{text-align:left}.tb-button--center{text-align:center}.tb-button--right{text-align:right}.tb-button__link{color:inherit;cursor:pointer;display:inline-block;line-height:100%;text-decoration:none !important;text-align:center;transition:all 0.3s ease}.tb-button__link:hover,.tb-button__link:focus,.tb-button__link:visited{color:inherit}.tb-button__link:hover .tb-button__content,.tb-button__link:focus .tb-button__content,.tb-button__link:visited .tb-button__content{font-family:inherit;font-style:inherit;font-weight:inherit;letter-spacing:inherit;text-decoration:inherit;text-shadow:inherit;text-transform:inherit}.tb-button__content{vertical-align:middle;transition:all 0.3s ease}.tb-button__icon{transition:all 0.3s ease;display:inline-block;vertical-align:middle;font-style:normal !important}.tb-button__icon::before{content:attr(data-font-code);font-weight:normal !important}.tb-button__link{background-color:#444;border-radius:0.3em;font-size:1.3em;margin-bottom:0.76em;padding:0.55em 1.5em 0.55em}.tb-button{color:#f1f1f1}.tb-button--left{text-align:left}.tb-button--center{text-align:center}.tb-button--right{text-align:right}.tb-button__link{color:inherit;cursor:pointer;display:inline-block;line-height:100%;text-decoration:none !important;text-align:center;transition:all 0.3s ease}.tb-button__link:hover,.tb-button__link:focus,.tb-button__link:visited{color:inherit}.tb-button__link:hover .tb-button__content,.tb-button__link:focus .tb-button__content,.tb-button__link:visited .tb-button__content{font-family:inherit;font-style:inherit;font-weight:inherit;letter-spacing:inherit;text-decoration:inherit;text-shadow:inherit;text-transform:inherit}.tb-button__content{vertical-align:middle;transition:all 0.3s ease}.tb-button__icon{transition:all 0.3s ease;display:inline-block;vertical-align:middle;font-style:normal !important}.tb-button__icon::before{content:attr(data-font-code);font-weight:normal !important}.tb-button__link{background-color:#444;border-radius:0.3em;font-size:1.3em;margin-bottom:0.76em;padding:0.55em 1.5em 0.55em} } 

Peter Belden appointed MD of Brecon Pharmaceuticals

January 20, 2010
Manufacturing and Production Brecon, appointment, manufacturing and production

Commercial packaging and clinical trials supplies services company Brecon Pharmaceuticals has appointed Peter Belden managing director. He was previously senior …

Appointment

Obama presses on in spite of public doubts

January 20, 2010
Sales and Marketing Obama, US healthcare

President Obama is making slow but steady progress towards making his healthcare reforms a reality – but is also steadily …

News

Lundbeck and Teva launch Azilect in France

January 20, 2010
Sales and Marketing Azilect, France, Lundbeck, Teva

Lundbeck and Teva France have launched Azilect in France following the successful conclusion of pricing and reimbursement discussions with the …

News

FDA to study effects of medication during pregnancy

January 20, 2010
Research and Development, Sales and Marketing FDA, paediatric

A new US-based collaborative research programme to study the effects of medication on mothers and their babies has been launched. …

News

GLOBALHealthPR expands into Turkey and India

January 20, 2010
Medical Communications Aurora, GLOBALhealthPR, Mediamedic Communications, OptimumBrand

The GLOBALHealthPR network of owner-managed comunications agencies has expanded, incorporating firms in Turkey and India. The introduction of OptimumBrand in …

News

Dr Kai Lindevall re-appointed chief executive of Encorium

January 20, 2010
Research and Development Encorium, appointment, research and development

Dr Kai Lindevall has been re-appointed chief executive of contract research organisation (CRO) Encorium, having held the post in 2008 …

Appointment

Dr Lloyd Payne joins Aquapharm Biodiscovery as research director

January 20, 2010
Research and Development Aquapharm Biodiscovery, appointment, research and development

Scottish marine biotechnology company Aquapharm Biodiscovery has appointed Dr Lloyd Payne as its new research director. He joins Aquapharm from …

Appointment

Chamberlain Healthcare PR appoints Mark Cater

January 20, 2010
Medical Communications Chamberlain Healthcare PR, appointment, medical communications

Mark Cater has been appointed managing director of Chamberlain Healthcare PR’s London office. Prior to joining Chamberlain, Cater was regional …

Appointment

University of Cambridge joins Lilly’s open innovation group

January 20, 2010
Research and Development Cambridge University, OIDD, University of Cambridge, lilly

The University of Cambridge is to join Eli Lilly’s ‘Open Innovation Drug Discovery’ project. Lilly first launched its online portal …

News

Boehringer targets ‘genome guardian’ protein for cancer collaboration

January 19, 2010
Research and Development Boehringer, Cancer, Priaxon, genome

Boehringer Ingelheim has signed a worldwide deal with Munich-based pharma firm Priaxon to find novel treatments for cancer. The firms …

News

Contract research news in brief

January 19, 2010
Research and Development Bioanalytical Systems, Charles River Laboratories, Invivodata, Quintiles, ReSearch Pharmaceutical, ReSearch Pharmaceutical Se Invivodata, Synomics Pharma

Our round-up of developments in the world of outsourced R&D includes job losses at Charles River, India’s SIRO Clinpharma buying …

News

Awards recognise top pharma manufacturing projects

January 19, 2010
Manufacturing and Production Biogen, Genentech, Mannkind, Pfizer

The winners of the 2010 Facility of the Year Awards have been made public, with Pfizer grabbing two out of …

News

AstraZeneca continues personalised healthcare push

January 19, 2010
Sales and Marketing AstraZeneca, Dako, Diagnostics, Iressa

AstraZeneca and cancer diagnostics specialist Dako Denmark are to develop companion diagnostics for a number of the pharma company’s oncology …

News

Victoza pill trial begins

January 19, 2010
Research and Development, Sales and Marketing GLP-1, Novo Nordisk, Victoza, diabetes, type II

A promising new diabetes treatment which can be taken as a pill instead of as an injection has just begun …

News

NICE approves Trabectedin

January 19, 2010
Sales and Marketing NICE, PharmaMar, Trabectedin, soft tissue sarcoma

Patients with advanced soft tissue sarcoma could now benefit from PharmaMar’s new drug trabectedin, after the NICE granted its approval. …

News

US generics company expands into Eastern Europe

January 19, 2010
Sales and Marketing Alvogen, Eastern Europe, generics

US generics company Alvogen has announced an ambitious expansion into the lucrative markets of Eastern Europe. The company has opened …

News

Sir Leszek Borysiewicz to step down from the MRC

January 19, 2010
MRC, UK, appointment

The Medical Research Council’s chief executive Sir Leszek Borysiewicz is stepping down later this year to become vice chancellor of …

Appointment

Avantium appoints Gunnar Staaf

January 19, 2010
Sales and Marketing appointment, sales and marketing

Amsterdam-based technology company Avantium has appointed Gunnar Staaf as chief executive of its pharma business in preparation for spinning it …

Appointment

Pharma responds to disaster in Haiti

January 18, 2010
Sales and Marketing Haiti, disaster, industry reputation, relief

A number of pharmaceutical companies have sprung into action to help the relief effort in Haiti. The island has been …

News

Commission probes Lundbeck on alleged generic blocking

January 18, 2010
Sales and Marketing European Commission, Lundbeck, generics, kroes

The European Commission has confirmed it is to investigate Lundbeck for alleged anti-competitive behaviour relating to its anti-depressant Cipramil. The …

News